The overlooked evidence for simple cleansing, moisturizing, and sun protection
A 2026 narrative review examined the nonmedicated ‘vehicle’ groups in controlled dermatology trials and found meaningful improvement across several conditions.
A 2026 narrative review examined the nonmedicated ‘vehicle’ groups in controlled dermatology trials and found meaningful improvement across several conditions.
Why it matters
It supports a lower-cost, lower-complexity starting point: consistent basic care can contribute substantially even when it is not the active treatment under study.
What we don't know
This was a narrative review, not a pooled meta-analysis or proof that basics replace treatment. One author disclosed honoraria, sponsorship, and speaker fees from several skincare and pharmaceutical companies.
What the authors looked at
The review examined outcomes in vehicle groups from randomized trials involving acne, actinic keratoses, melasma, post-inflammatory hyperpigmentation, and rosacea. A vehicle is the base formulation without the studied active drug, so its results can reveal the contribution of moisturization, cleansing, sun protection, study behavior, and natural change over time.
What the signal can—and cannot—support
The paper argues that basic skincare should be treated as part of dermatologic care, not as empty background. That is compatible with using prescribed treatment when it is needed.
Vehicle results do not mean every moisturizer is equivalent, that a condition will resolve without medical care, or that the active treatment added no value. They are a reminder to measure the whole routine.
Open the source file
These links support the claims above. Source dates, disclosures and limits are documented in the article and source list.